ChEMBL_ID,canonical_smiles,standard_value,standard_units,assay_description,activity_flag,Mol,MolWt,LogP
CHEMBL4294646,O=C(O)CN1C(=O)/C(=C/c2nc3cc(Cl)ccc3n2Cc2ccccc2F)SC1=S,5640.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696f90>,461.92700000000013,4.162900000000002
CHEMBL4293594,Cc1ccc(Cn2c(/C=C3\SC(=S)NC3=O)nc3ccccc32)cc1,5310.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696f20>,365.4830000000001,3.881820000000002
CHEMBL5192712,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)N4CCN(C(=O)CN5C(=O)S/C(=C\c6ccc7c(c6)OCO7)C5=O)CC4)CC[C@]3(C)CC[C@]12C,350.0,nM,Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 96 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696dd0>,808.0099999999998,7.749100000000009
CHEMBL5172244,COc1ccc(C/N=C2\NC(=O)/C(=C3\CCNC(=O)c4[nH]c5ccccc5c43)S2)cc1,3730.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696970>,432.5050000000001,3.4403000000000015
CHEMBL2316329,CC1Oc2ccc(Br)cc2C=C1/C=C1\SC(=S)N(CC(=O)O)C1=O,50000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b696900>,426.31300000000016,3.4422000000000024
CHEMBL363555,CCOc1ccc(/C=C2\SC(=O)N(CCN)C2=O)cc1,25000.0,nM,Inhibitory concentration against growth of A549 lung carcinoma cell,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b696820>,292.35999999999996,2.0803
CHEMBL4292926,O=C(O)CN1C(=O)/C(=C/c2nc3ccccc3n2Cc2ccccc2)SC1=S,8760.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b6967b0>,409.4920000000001,3.3704000000000027
CHEMBL4591565,COc1ccc2oc(=O)c(/C=C3\SC(=O)N(C(=O)c4ccc(Cl)cc4)C3=O)cc2c1,950.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696740>,441.8480000000002,4.331700000000003
CHEMBL3792481,Cc1cnc(C(=O)NN2C(=O)CS[C@H]2c2ccc(N(C)C)cc2)cn1,279768.01636083354,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b6965f0>,357.4390000000001,1.77002
CHEMBL4585340,CCN1CCN(CCCOc2cc3nccc(Oc4ccc(C5SCC(=O)N5NC(=O)Nc5ccc(F)cc5F)cc4F)c3cc2OC)CC1,1000.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696580>,710.7790000000001,6.170100000000007
CHEMBL4442035,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccccc4)cc3)ccnc2cc1OCCCN1CCOCC1,8700.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696510>,629.7389999999997,5.447500000000004
CHEMBL4284355,Cc1ccc(Cn2c(/C=C3\SC(=S)N(CCC(=O)O)C3=O)nc3ccccc32)cc1,8740.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696430>,437.54600000000016,4.068920000000003
CHEMBL3794067,COc1ccc([C@H]2SCC(=O)N2NC(=O)c2nccnc2N)cc1OC,213153.6187102101,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696200>,375.4100000000001,0.9949999999999999
CHEMBL4218483,COc1cc(OC)c(-c2nc3cc(/C=C4\SC(=O)NC4=O)ccc3[nH]2)cc1OC,1840.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b696040>,411.43900000000014,3.579600000000001
CHEMBL3098830,Cc1ccc(C(=O)CN2C(=O)S/C(=C\C3=C(Cl)c4ccccc4CCC3)C2=O)cc1,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b672660>,437.94800000000026,5.743420000000005
CHEMBL4202950,COc1cc(-c2nc3cc(/C=C4\SC(=O)N(CC(=O)c5ccccc5)C4=O)ccc3[nH]2)cc(OC)c1OC,880.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672270>,529.5740000000002,5.174900000000005
CHEMBL4289418,Cc1ccc(Cn2c(/C=C3\SC(=S)N(CC(=O)O)C3=O)nc3ccc(Cl)cc32)cc1,9970.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672ac0>,457.9640000000002,4.332220000000003
CHEMBL4211815,COc1cc(-c2nc3cc(/C=C4\SC(=O)N(CC(=O)N5CCCC5)C4=O)ccc3[nH]2)cc(OC)c1OC,910.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b6723c0>,522.5830000000004,3.914400000000003
CHEMBL4550253,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccccc4Cl)cc3)ccnc2cc1OCCCN1CCOCC1,8500.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672890>,664.1839999999996,6.100900000000006
CHEMBL4460608,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3Cl)ccnc2cc1OCCCN1CCOCC1,6700.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672820>,700.1639999999995,6.379100000000006
CHEMBL3098836,COc1ccc(C(=O)CN2C(=O)S/C(=C\C3=C(Cl)c4cc(C)c(C)cc4CCC3)C2=O)cc1,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b6729e0>,482.0010000000003,6.060440000000005
CHEMBL4472209,CCN(CC)CCCOc1cc2nccc(Oc3c(F)cc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)c2cc1OC,450.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672f90>,687.7160000000002,7.013500000000007
CHEMBL4276731,O=C(O)CN1C(=O)/C(=C/c2nc3ccccc3n2Cc2ccc(Br)cc2)SC1=S,9120.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672eb0>,488.3880000000001,4.132900000000003
CHEMBL3793638,CCOc1cc([C@@H]2SCC(=O)N2NC(=O)c2cnc(C)cn2)ccc1O,267078.323389117,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672d60>,374.4220000000001,1.8083199999999997
CHEMBL4206739,COc1cc(-c2nc3cc(/C=C4\SC(=O)NC4=O)ccc3[nH]2)ccc1OCC(C)C,5110.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672510>,423.4940000000002,4.597200000000003
CHEMBL5192072,Cc1ccc(C/N=C2\NC(=O)/C(=C3\CCNC(=O)c4[nH]c5ccccc5c43)S2)cc1,1240.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b672040>,416.5060000000001,3.740120000000002
CHEMBL565219,C=CCc1cc(/C=C2\SC(=O)NC2=O)c(O)c(-c2ccc(O)c(CC=C)c2)c1,91600.0,nM,Antiproliferative activity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b672120>,393.4640000000001,4.545700000000003
CHEMBL4281869,CCn1c(/C=C2\SC(=S)N(CC(=O)O)C2=O)nc2ccccc21,9440.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad076d0>,347.42100000000005,2.3420000000000005
CHEMBL4763026,O=C1NC(=O)/C(=C/c2ccc(-c3nc4c5ccccc5c5ccccc5c4[nH]3)cc2)S1,1700.0,nM,Cytotoxicity against human A549/ATCC assessed as reduction in cell viability after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad077b0>,421.4810000000001,5.860200000000003
CHEMBL4577182,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4cccc(Cl)c4)cc3)ccnc2cc1OCCCN1CCOCC1,8900.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07200>,664.1839999999996,6.100900000000006
CHEMBL262615,CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1,25000.0,nM,Antiproliferative activity against human A549 cells,inactive,<rdkit.Chem.rdchem.Mol object at 0x16ad07f20>,292.35999999999996,2.0803
CHEMBL3794212,Cc1cnc(C(=O)NN2C(=O)CS[C@@H]2c2cccc([N+](=O)[O-])c2)cn1,278267.0640320341,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07eb0>,359.3670000000001,1.6122199999999998
CHEMBL360496,CC(=O)OC[C@]12C[C@H]3OC4(O)[C@@H](O[C@H](C)C[C@@]45NC(=O)CS5)O[C@@H]3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12CO,1861.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16ad070b0>,661.8140000000002,2.8109000000000015
CHEMBL175921,C[C@@H]1C[C@@]2(NC(=O)CS2)C2(O)O[C@@H]3C[C@@]4(COC(=O)c5ccccc5)[C@@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@@H](C6=CC(=O)OC6)CC[C@]54CO)C[C@H]3O[C@@H]2O1,625.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07040>,723.8850000000001,4.104800000000003
CHEMBL4216605,O=C(O)CN1C(=O)/C(=C/c2ccc3c(c2)c2ccccc2n3Cc2ccc(Br)cc2F)SC1=S,9440.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07f90>,555.4500000000002,6.030200000000003
CHEMBL1213862,O=C1NC(=O)/C(=C2/C(=O)Nc3ccccc32)S1,60700.0,nM,Antiproliferative activity against apoptosis resistant human A549 cells after 72 hrs by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16ad07e40>,246.247,1.3328
CHEMBL3098841,O=C(CN1C(=O)CSC1=O)c1ccc(Cl)cc1,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16ad07dd0>,269.709,2.2180999999999997
CHEMBL3098839,Cc1ccc(C(=O)CN2C(=O)CSC2=O)cc1,17030.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16ad07c80>,249.291,1.87312
CHEMBL5196368,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)N4CCN(C(=O)CN5C(=O)S/C(=C\c6ccco6)C5=O)CC4)CC[C@]3(C)CC[C@]12C,170.0,nM,Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 96 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07c10>,753.9619999999999,7.613400000000009
CHEMBL3098831,COc1ccc(C(=O)CN2C(=O)S/C(=C\C3=C(Cl)c4ccccc4CCC3)C2=O)cc1,5440.0,nM,Cytotoxicity against human A549 cells by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07970>,453.94700000000023,5.443600000000004
CHEMBL4209079,COc1ccc(-c2nc3cc(/C=C4\SC(=O)NC4=O)ccc3[nH]2)cc1OC,570.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07900>,381.4130000000001,3.5710000000000015
CHEMBL3261573,COc1ccccc1N1C(=O)CSC1c1cccc(C(=O)NCCc2ccc(Br)cc2)c1,210.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07740>,511.4410000000002,5.2088000000000045
CHEMBL4445015,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4cc(F)cc(F)c4)cc3)ccnc2cc1OCCCN1CCOCC1,6100.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad075f0>,665.7189999999996,5.725700000000006
CHEMBL4467951,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)c(Cl)c3)ccnc2cc1OCCCN1CCOCC1,6100.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07510>,700.1639999999995,6.379100000000006
CHEMBL175716,Cc1ccc(S(=O)(=O)OC[C@]23C[C@H]4OC5(O)[C@@H](O[C@H](C)C[C@@]56NC(=O)CS6)O[C@@H]4C[C@@H]2CC[C@@H]2[C@@H]3CC[C@]3(C)[C@@H](C4=CC(=O)OC4)CC[C@]23CO)cc1,48.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16ad074a0>,773.9669999999999,3.9617200000000024
CHEMBL4562312,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)c(F)c3)ccnc2cc1OCCCN1CCOCC1,4600.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad073c0>,683.7089999999996,5.864800000000006
CHEMBL3261578,COc1ccccc1N1C(=O)CSC1c1cccc(C(=O)NCCc2ccc(O)cc2)c1,720.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07190>,448.5440000000002,4.151900000000003
CHEMBL3261541,COc1ccccc1N1C(=O)CSC1c1cccc(Br)c1,1870.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16ad07120>,364.264,4.236300000000003
CHEMBL2316318,CCN1C(=O)S/C(=C\C2=Cc3ccccc3OC2)C1=O,200000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16acfd820>,287.3400000000001,3.061600000000001
CHEMBL3792993,O=C(NN1C(=O)CS[C@@H]1c1ccc(Cl)cc1)c1cnccn1,298696.4885240809,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfdeb0>,334.78800000000007,2.049
CHEMBL3098832,O=C(CN1C(=O)S/C(=C\C2=C(Cl)c3ccccc3CCC2)C1=O)c1ccc(Cl)cc1,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16acfdc10>,458.3660000000002,6.0884000000000045
CHEMBL4456494,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4)cc3)ccnc2cc1OCCCN1CCOCC1,4900.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd900>,647.7289999999996,5.586600000000005
CHEMBL4455726,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCOCC1,2100.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd4a0>,683.7089999999996,5.864800000000006
CHEMBL3792977,Nc1nccnc1C(=O)NN1C(=O)CSC1c1ccccc1,244293.7867439545,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfddd0>,315.358,0.9777999999999994
CHEMBL1910509,O=C1NC(=O)/C(=C/c2c[nH]c3ccccc23)S1,87700.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16acfde40>,244.275,2.4918000000000005
CHEMBL368047,C[C@@H]1C[C@@]2(NC(=O)CS2)[C@]2(O)O[C@@H]3C[C@@]4(C=O)[C@@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@@H](C6=CC(=O)OC6)CC[C@]54CO)C[C@H]3O[C@@H]2O1,74.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16acfdcf0>,617.7610000000004,2.4467
CHEMBL3088155,COc1ccc(/C=C2\S/C(=N\c3nc(-c4c(C)n(C)n(-c5ccccc5)c4=O)cs3)N(c3ccccc3)C2=O)cc1,9100.0,nM,Cytotoxicity against human A549 cells after 72 hrs by SRB assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfdc80>,579.7070000000002,6.425120000000006
CHEMBL4483794,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCc2sccc2C1,20000.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16acfda50>,753.7999999999996,7.791500000000006
CHEMBL3794581,CCOc1cc([C@H]2SCC(=O)N2NC(=O)c2nccnc2N)ccc1O,224208.1990357209,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd970>,375.4100000000001,1.0820999999999996
CHEMBL4462007,COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3Cl)ccnc2cc1OCCCN1CCCC1,880.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd7b0>,684.1649999999995,7.142700000000006
CHEMBL4451737,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,510.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd740>,714.7419999999995,5.9191000000000065
CHEMBL175769,CC(=O)CCC(=O)OC[C@]12C[C@H]3OC4(O)[C@@H](O[C@H](C)C[C@@]45NC(=O)CS5)O[C@@H]3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12CO,463.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd6d0>,717.878,3.160200000000002
CHEMBL3098844,Cc1cc2c(cc1C)C(Cl)=C(/C=C1\SC(=O)NC1=O)CCC2,5390.0,nM,Cytotoxicity against human A549 cells by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd660>,333.84000000000015,4.456540000000003
CHEMBL3261576,COc1ccccc1N1C(=O)CSC1c1cccc(C(=O)NCCc2ccc(Cl)cc2)c1,160.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd5f0>,466.99000000000024,5.099700000000005
CHEMBL3261564,COC(=O)c1cccc(C2SCC(=O)N2c2ccccc2OC)c1,290.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd580>,343.40400000000005,3.2604000000000024
CHEMBL4293343,Cc1ccc(Cn2c(/C=C3\SC(=S)N(CC(=O)O)C3=O)nc3ccccc32)cc1,3220.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd510>,423.5190000000002,3.6788200000000018
CHEMBL4160329,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3)ccnc2cc1OCCCN1CCOCC1,6000.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd3c0>,665.7189999999996,5.725700000000006
CHEMBL4582080,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(Cl)cc4)cc3)ccnc2cc1OCCCN1CCOCC1,6700.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd270>,664.1839999999996,6.100900000000006
CHEMBL4472443,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCC(N2CCCCC2)CC1,380.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd120>,782.8609999999992,7.622000000000009
CHEMBL4522971,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1C[C@H]2CCCC[C@H]2C1,1930.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16acfd200>,739.7919999999995,7.793700000000007
CHEMBL1213806,O=C1NC(=S)S/C1=C1\C(=O)Nc2ccccc21,99000.0,nM,Antiproliferative activity against apoptosis resistant human A549 cells after 72 hrs by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16acfd190>,262.31500000000005,1.4976999999999998
CHEMBL4215478,COc1ccc(-c2nc3cc(/C=C4\SC(=O)N(CC(=O)c5ccccc5)C4=O)ccc3[nH]2)cc1OC,740.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b855c80>,499.54800000000023,5.166300000000005
CHEMBL4291623,C=C1C(=O)[C@]23[C@H](O)[C@H]1C[C@H](O)[C@H]2[C@]12CCCC(C)(C)[C@H]1C[C@H]3O[C@@H]2OCCCn1cc(CN2C(=O)SC(=C(C)C)C2=O)nn1,9200.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b855ba0>,626.7760000000001,3.598600000000002
CHEMBL3794545,Cc1cnc(C(=O)NN2C(=O)CS[C@@H]2c2ccc([N+](=O)[O-])cc2)cn1,278267.0640320341,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b855b30>,359.3670000000001,1.6122199999999998
CHEMBL3261558,COc1ccccc1N1C(=O)CSC1c1cccc(Cl)c1,8180.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b855ac0>,319.813,4.127200000000003
CHEMBL4280306,C=C1C(=O)[C@]23[C@H](O)[C@H]1C[C@H](O)[C@H]2[C@]12CCCC(C)(C)[C@H]1C[C@H]3O[C@@H]2OCCCn1cc(CN2C(=O)S/C(=C/CCCCC)C2=O)nn1,4800.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b855a50>,668.8569999999999,4.768900000000005
CHEMBL4294458,COc1ccc2c(c1)nc(/C=C1\SC(=S)N(CC(=O)O)C1=O)n2Cc1ccc(C)cc1,5680.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b8559e0>,453.5450000000003,3.687420000000002
CHEMBL4286115,O=C(O)CN1C(=O)/C(=C/c2nc3ccccc3n2Cc2ccccc2F)SC1=S,2670.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b855900>,427.4820000000001,3.5095000000000027
CHEMBL4285092,O=C(O)CN1C(=O)/C(=C/c2nc3ccccc3n2Cc2ccc(F)cc2)SC1=S,3570.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b855890>,427.4820000000001,3.5095000000000027
CHEMBL4291331,COc1ccc(C(=O)Cn2c(/C=C3\SC(=S)N(CC(=O)O)C3=O)nc3ccccc32)cc1,5150.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b855820>,467.5280000000002,3.2136000000000013
CHEMBL4288578,Cc1ccc(C(=O)Cn2c(/C=C3\SC(=S)N(CC(=O)O)C3=O)nc3ccccc32)cc1,9460.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b8556d0>,451.5290000000002,3.5134200000000018
CHEMBL4294863,COc1c(/C=C2\SC(=S)NC2=O)c(NS(=O)(=O)c2cccs2)cc2c1OCO2,14700.0,nM,Growth inhibition of human A549 cells expressing mutant KRAS incubated for 72 hrs by MTS assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b855510>,456.54800000000023,2.7750000000000004
CHEMBL4283758,C=C1C(=O)[C@]23[C@H](O)[C@H]1C[C@H](O)[C@H]2[C@]12CCCC(C)(C)[C@H]1C[C@H]3O[C@@H]2OCCCn1cc(CN2C(=O)S/C(=C/C)C2=O)nn1,3500.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b8554a0>,612.7490000000001,3.2085000000000017
CHEMBL175719,CC(O)CCC(=O)OC[C@]12C[C@H]3OC4(O)[C@@H](O[C@H](C)C[C@@]45NC(=O)CS5)O[C@@H]3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12CO,414.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16b855430>,719.894,2.952000000000002
CHEMBL4214639,N#Cc1ccc(Cn2c3ccccc3c3cc(/C=C4\SC(=S)N(CC(=O)O)C4=O)ccc32)cc1,2180.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b8553c0>,483.57400000000024,5.0002800000000045
CHEMBL3098837,Cc1cc2c(cc1C)C(Cl)=C(/C=C1\SC(=O)N(CC(=O)c3ccc(Cl)cc3)C1=O)CCC2,3490.0,nM,Cytotoxicity against human A549 cells by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b590580>,486.42000000000036,6.705240000000006
CHEMBL4210895,O=C(O)CN1C(=O)/C(=C/c2ccc3c(c2)c2ccccc2n3Cc2ccc([N+](=O)[O-])cc2)SC1=S,3940.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b590b30>,503.5610000000002,5.036800000000004
CHEMBL2316324,CC1Oc2ccc(Br)cc2C=C1/C=C1\SC(=S)NC1=O,47500.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b590f90>,368.27700000000004,3.6452000000000018
CHEMBL5170428,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)N4CCN(C(=O)CN5C(=O)CSC5=O)CC4)CC[C@]3(C)CC[C@]12C,1550.0,nM,Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 96 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b590c80>,675.8919999999998,5.9793000000000065
CHEMBL3261537,O=C1CSC(c2cccc(Br)c2)N1c1cc(Cl)ccc1O,9950.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b590c10>,384.682,4.586700000000002
CHEMBL4295191,COc1cc(Cn2c(/C=C3\SC(=S)N(CC(=O)O)C3=O)nc3ccccc32)cc(OC)c1,5170.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b590ba0>,469.5440000000002,3.3876000000000017
CHEMBL4204692,COc1cc(-c2nc3cc(/C=C4\SC(=O)N(Cc5ccccc5)C4=O)ccc3[nH]2)cc(OC)c1OC,670.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5909e0>,501.56400000000025,5.492200000000006
CHEMBL4208063,COc1cc(-c2nc3cc(/C=C4\SC(=O)N(CC(=O)N5CCOCC5)C4=O)ccc3[nH]2)cc(OC)c1OC,2930.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b590900>,538.5820000000003,3.150800000000001
CHEMBL4446992,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,650.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5906d0>,696.7519999999995,5.780000000000006
CHEMBL4218601,COc1cc(CN2C(=O)S/C(=C\c3ccc4[nH]c(-c5cc(OC)c(OC)c(OC)c5)nc4c3)C2=O)cc(OC)c1OC,530.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b590190>,591.6420000000003,5.518000000000005
CHEMBL4460407,CCN1CCN(CCCCOc2cc3nccc(Oc4c(F)cc(NC(=O)NN5C(=O)CSC5c5c(F)cccc5F)cc4F)c3cc2OC)CC1,1390.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b590120>,742.7960000000002,6.699300000000006
CHEMBL5173685,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)N4CCN(C(=O)CN5C(=O)S/C(=C\C(C)C)C5=O)CC4)CC[C@]3(C)CC[C@]12C,90.0,nM,Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 96 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5900b0>,729.9839999999998,7.519200000000009
CHEMBL4470627,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)C(C)SC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCCC1,830.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56aeb0>,699.7269999999995,7.156000000000007
CHEMBL4552334,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,970.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56ae40>,713.7539999999996,7.403600000000007
CHEMBL4218732,COc1cc(OC)c(-c2nc3cc(/C=C4\SC(=O)N(Cc5cccc(C)c5)C4=O)ccc3[nH]2)cc1OC,130.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56acf0>,515.5910000000002,5.800620000000006
CHEMBL4280189,O=C(O)CN1C(=O)/C(=C/c2nc3ccccc3n2CC(=O)c2ccc(Cl)cc2)SC1=S,9850.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56ac80>,471.9470000000002,3.858400000000003
CHEMBL4295041,C=C1C(=O)[C@]23[C@H](O)[C@H]1C[C@H](O)[C@H]2[C@]12CCCC(C)(C)[C@H]1C[C@H]3O[C@@H]2OCCCn1cc(CN2C(=O)S/C(=C/CC)C2=O)nn1,7800.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56ac10>,626.7760000000001,3.598600000000002
CHEMBL4437195,COc1cc2c(Oc3c(F)cc(NC(=S)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCCC1,690.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56aba0>,701.7679999999996,6.932400000000006
CHEMBL5178704,Cc1ccc(C/N=C2\NC(=O)/C(=C3\CCNC(=O)c4[nH]ccc43)S2)cc1,9080.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56ab30>,366.446,2.58692
CHEMBL1910508,O=C1NC(=O)/C(=C/c2c(-c3ccccc3)[nH]c3ccc(Cl)cc23)S1,4500.0,nM,Cytotoxicity against human A549 cells by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56a970>,354.81800000000004,4.812200000000002
CHEMBL3794028,COc1cc([C@@H]2SCC(=O)N2NC(=O)c2cnc(C)cn2)ccc1O,172754.89393582035,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b56a190>,360.3950000000001,1.4182199999999998
CHEMBL3098834,Cc1cc2c(cc1C)C(Cl)=C(/C=C1\SC(=O)N(CC(=O)c3ccccc3)C1=O)CCC2,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b56a120>,451.9750000000003,6.051840000000006
CHEMBL434923,C[C@@H]1C[C@@]2(NC(=O)CS2)C2(O[Si](C)(C)C)O[C@@H]3C[C@@]4(CO[Si](C)(C)C)[C@@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@@H](C6=CC(=O)OC6)CC[C@]54CO[Si](C)(C)C)C[C@H]3O[C@@H]2O1,657.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16b56a0b0>,836.326,7.817700000000009
CHEMBL2316333,CN1C(=O)S/C(=C\C2=Cc3ccccc3OC2)C1=O,100000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b549f20>,273.31300000000005,2.6715
CHEMBL3261570,COc1ccccc1N1C(=O)CSC1c1cccc(C(=O)NCc2ccccc2)c1,5060.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b549ba0>,418.51800000000014,4.403800000000003
CHEMBL3261574,COc1ccccc1N1C(=O)CSC1c1cccc(C(=O)NCCc2ccccc2Br)c1,8520.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b549dd0>,511.4410000000002,5.2088000000000045
CHEMBL4468182,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCN1CCC(N2CCCCC2)CC1,2380.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b549cf0>,768.8339999999993,7.231900000000008
CHEMBL4289180,Cc1ccc(Cn2c(/C=C3\SC(=S)N(CC(=O)O)C3=O)nc3ccc(F)cc32)cc1,9640.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b549c80>,441.5090000000002,3.8179200000000018
CHEMBL4205346,COc1cc(-c2nc3cc(/C=C4\SC(=O)N(Cc5cccc(C)c5)C4=O)ccc3[nH]2)cc(OC)c1OC,930.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b549970>,515.5910000000002,5.8006200000000065
CHEMBL3098833,O=C(CN1C(=O)S/C(=C\C2=C(Cl)c3ccccc3CCC2)C1=O)c1ccc(Br)cc1,5750.0,nM,Cytotoxicity against human A549 cells by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b549900>,502.81700000000023,6.197500000000004
CHEMBL558653,C=CCc1ccc(O)c(-c2cc(/C=C3\SC(=O)NC3=O)c(O)c(CC=C)c2)c1,101800.0,nM,Antiproliferative activity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b5469e0>,393.4640000000001,4.545700000000003
CHEMBL2316323,CC1Oc2ccc(Br)cc2C=C1/C=C1\SC(=O)NC1=O,65500.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b546900>,352.20900000000006,3.4803000000000015
CHEMBL560335,C=CCc1cc(/C=C2\SC(=O)NC2=O)c(O)c(-c2cc(/C=C3\SC(=O)NC3=O)c(O)c(CC=C)c2)c1,76900.0,nM,Antiproliferative activity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b546820>,520.5880000000003,4.869600000000004
CHEMBL3098829,O=C(CN1C(=O)S/C(=C\C2=C(Cl)c3ccccc3CCC2)C1=O)c1ccccc1,4890.0,nM,Cytotoxicity against human A549 cells by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5467b0>,423.9210000000002,5.435000000000004
CHEMBL3098840,COc1ccc(C(=O)CN2C(=O)CSC2=O)cc1,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b546740>,265.28999999999996,1.5733
CHEMBL3098835,Cc1ccc(C(=O)CN2C(=O)S/C(=C\C3=C(Cl)c4cc(C)c(C)cc4CCC3)C2=O)cc1,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b5466d0>,466.00200000000035,6.360260000000006
CHEMBL1305855,O=C(CN1C(=O)CSC1=O)c1ccccc1,14100.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b546580>,235.264,1.5646999999999998
CHEMBL4584914,CCN1CCN(CCOc2cc3nccc(Oc4c(F)cc(NC(=O)NN5C(=O)CSC5c5c(F)cccc5F)cc4F)c3cc2OC)CC1,1520.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b546510>,714.7420000000001,5.919100000000006
CHEMBL4460068,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCCC1,560.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b546430>,685.6999999999996,6.767500000000006
CHEMBL3261571,COc1ccccc1N1C(=O)CSC1c1cccc(C(=O)NCCc2ccccc2)c1,960.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b546350>,432.5450000000002,4.4463000000000035
CHEMBL1910507,Cc1ccc2[nH]c(-c3ccccc3)c(/C=C3\SC(=O)NC3=O)c2c1,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b546040>,334.4000000000001,4.467220000000003
CHEMBL552054,C[C@@H]1CC2(NC(=O)CS2)[C@]2(O)O[C@@H]3C[C@@]4(CO)[C@@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@@H](C6=CC(=O)OC6)CC[C@]54O)C[C@H]3O[C@@H]2O1,8.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b503f90>,605.7500000000005,1.9924999999999988
CHEMBL4586642,COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)c(Cl)c3)ccnc2cc1OCCCN1CCCC1,960.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b503f20>,684.1649999999995,7.142700000000006
CHEMBL366970,C[C@@H]1C[C@@]2(NC(=O)CS2)C2(O)O[C@@H]3C[C@@]4(COS(C)(=O)=O)[C@@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@@H](C6=CC(=O)OC6)CC[C@]54CO)C[C@H]3O[C@@H]2O1,3652.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16b503eb0>,697.8690000000001,2.224000000000001
CHEMBL4215304,COc1cc(OC)c(-c2nc3cc(/C=C4\SC(=O)N(CC(=O)N5CCOCC5)C4=O)ccc3[nH]2)cc1OC,660.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b503dd0>,538.5820000000003,3.150800000000001
CHEMBL3261577,COc1ccc(CCNC(=O)c2cccc(C3SCC(=O)N3c3ccccc3OC)c2)cc1,130.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b503d60>,462.57100000000025,4.454900000000004
CHEMBL178993,C[C@@H]1C[C@@]2(NC(=O)CS2)C2(O)O[C@@H]3C[C@@]4(CO)[C@@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@@H](C6=CC(=O)OC6)CC[C@]54CO)C[C@H]3O[C@@H]2O1,8.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,active,<rdkit.Chem.rdchem.Mol object at 0x16b503cf0>,619.7770000000004,2.240099999999999
CHEMBL3098843,O=C1NC(=O)/C(=C/C2=C(Cl)c3ccccc3CCC2)S1,100000.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b503c80>,305.78600000000006,3.8397000000000023
CHEMBL2062759,O=C(O)CN1C(=O)/C(=C/C2=Cc3ccccc3OC2)SC1=S,100000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b503c10>,333.39000000000004,2.291200000000001
CHEMBL3098838,Cc1cc2c(cc1C)C(Cl)=C(/C=C1\SC(=O)N(CC(=O)c3ccc(Br)cc3)C1=O)CCC2,9690.0,nM,Cytotoxicity against human A549 cells by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b503ba0>,530.8710000000001,6.814340000000006
CHEMBL4462008,COc1cc2c(Oc3c(F)cc(NC(=O)NN4C(=O)C(C)(C)SC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCCC1,1450.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b503ac0>,713.7539999999996,7.546100000000007
CHEMBL3261543,CCOc1ccc(N2C(=O)CSC2c2cccc(Br)c2)cc1,8980.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b503a50>,378.291,4.626400000000004
CHEMBL3261575,COc1ccccc1N1C(=O)CSC1c1cccc(C(=O)NCCc2ccc(F)cc2)c1,470.0,nM,Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5039e0>,450.5350000000002,4.5854000000000035
CHEMBL4205443,COc1cc(-c2nc3cc(/C=C4\SC(=O)N(Cc5cc(OC)c(OC)c(OC)c5)C4=O)ccc3[nH]2)ccc1OCC(C)C,96.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b500eb0>,603.6970000000002,6.535600000000007
CHEMBL3793789,O=C(NN1C(=O)CS[C@@H]1c1ccc([N+](=O)[O-])cc1)c1cnccn1,289569.69942665193,nM,Cytotoxicity against human A549 cells after 3 days by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b500e40>,345.34000000000003,1.3037999999999998
CHEMBL2316330,CCN1C(=O)S/C(=C\C2=Cc3cccc(OC)c3OC2)C1=O,200000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b500dd0>,317.3660000000001,3.0702000000000016
CHEMBL5177456,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)N4CCN(C(=O)CN5C(=O)S/C(=C\C6CC6)C5=O)CC4)CC[C@]3(C)CC[C@]12C,80.0,nM,Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 96 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b500d60>,727.9679999999997,7.273200000000009
CHEMBL2316319,O=C1NC(=O)/C(=C/C2=Cc3cc(Br)ccc3OC2)S1,79500.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b500cf0>,338.1820000000001,3.091800000000001
CHEMBL3793867,O=C1NC(=S)S/C1=C1\C(=O)Nc2ccc(Br)cc21,36200.0,nM,Antiproliferative activity against apoptosis resistant human A549 cells after 72 hrs by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b500ba0>,341.21100000000007,2.2602
CHEMBL4202977,O=C(O)CN1C(=O)/C(=C/c2ccc3c(c2)c2ccccc2n3Cc2ccc(C(F)(F)F)cc2)SC1=S,3400.0,nM,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b500b30>,526.5610000000001,6.147400000000004
CHEMBL4563995,COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)c4ccccc34)ccnc2cc1OCCCN1CCCC1,2360.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b500a50>,699.7799999999996,7.642500000000007
CHEMBL4214070,COc1cc(-c2nc3cc(/C=C4\SC(=O)NC4=O)ccc3[nH]2)cc(OC)c1OC,3570.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5009e0>,411.4390000000002,3.579600000000002
CHEMBL3098842,O=C(CN1C(=O)CSC1=O)c1ccc(Br)cc1,22700.0,nM,Cytotoxicity against human A549 cells by MTT assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b500890>,314.15999999999997,2.3272000000000004
CHEMBL2062729,O=C1NC(=S)S/C1=C\C1=Cc2ccccc2OC1,73100.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b500820>,275.3540000000001,2.4942
CHEMBL367694,C[C@@H]1C[C@@]2(NC(=O)CS2)C2(O)O[C@@H]3C[C@@]4(COC(=O)CCc5ccccc5)[C@@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@@H](C6=CC(=O)OC6)CC[C@]54CO)C[C@H]3O[C@@H]2O1,10000.0,nM,Concentration required for 50% growth inhibition of human A549 cancer cell lines after 3 days of culture,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b5007b0>,751.9390000000001,4.4238000000000035
CHEMBL2316327,CC1Oc2ccc(Br)cc2C=C1/C=C1\SC(=O)N(C)C1=O,50000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b5005f0>,366.2360000000001,3.8225000000000025
CHEMBL4456688,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)c(F)c4F)cc3)ccnc2cc1OCCCN1CCOCC1,5500.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5004a0>,683.7089999999996,5.864800000000006
CHEMBL4170935,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccccc4F)cc3)ccnc2cc1OCCCN1CCOCC1,7000.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5003c0>,647.7289999999996,5.586600000000005
CHEMBL4206589,COc1ccc(-c2nc3cc(/C=C4\SC(=O)N(CC(=O)N5CCOCC5)C4=O)ccc3[nH]2)cc1OC,8930.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b500120>,508.5560000000004,3.1422000000000008
CHEMBL4206860,COc1ccc(-c2nc3cc(/C=C4\SC(=O)N(Cc5cc(OC)c(OC)c(OC)c5)C4=O)ccc3[nH]2)cc1OC,130.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b5000b0>,561.6160000000003,5.509400000000006
CHEMBL2316328,CCN1C(=O)S/C(=C\C2=Cc3cc(Br)ccc3OC2C)C1=O,100000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b500040>,380.2630000000001,4.212600000000003
CHEMBL4587222,CCN1CCN(CCCOc2cc3nccc(Oc4c(F)cc(NC(=O)NN5C(=O)CSC5c5c(F)cccc5F)cc4F)c3cc2OC)CC1,350.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b4e0f90>,728.7690000000001,6.309200000000006
CHEMBL2316320,O=C1NC(=S)S/C1=C\C1=Cc2cc(Br)ccc2OC1,51000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b4e0f20>,354.2500000000001,3.2567000000000013
CHEMBL4160512,COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCCC1,690.0,nM,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b4e0b30>,667.7099999999996,6.628400000000006
CHEMBL2316334,O=C1NC(=O)/C(=C/C2=Cc3ccccc3OC2)S1,192200.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b4e0ac0>,259.28599999999994,2.3293
CHEMBL2316322,O=C(O)CN1C(=O)/C(=C/C2=Cc3cc(Br)ccc3OC2)SC1=S,25000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b4e0a50>,412.2860000000001,3.053700000000002
CHEMBL4440871,COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCCN(C)CC1,710.0,nM,Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b4e0970>,710.7789999999994,6.170100000000007
CHEMBL2316331,COc1cccc2c1OCC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C2,200000.0,nM,Anticancer activity against human A549 cells assessed as cell viability after 72 hrs by MTT reduction assay,inactive,<rdkit.Chem.rdchem.Mol object at 0x16b4e0900>,363.4160000000001,2.2997999999999994
CHEMBL4202441,COc1cc(-c2nc3cc(/C=C4\SC(=O)N(CC(=O)N5CCCCC5)C4=O)ccc3[nH]2)cc(OC)c1OC,980.0,nM,Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay,active,<rdkit.Chem.rdchem.Mol object at 0x16b4e0820>,536.6100000000004,4.3045000000000035
